KURA
Kura Oncology·NASDAQ
--
--(--)
--
--(--)
6.31 / 10
Outperform
Technical assessment reveals 6.31/10 overall, indicating favorable technical configuration with constructive signals in WR Oversold, Marubozu White, and Long Upper Shadow, though mitigated by adverse signals in no significant factors. Technical forecast: cautiously optimistic.
Analysis Checks(3/3)
Long Upper Shadow
Score6.94/10
Win Rate60.00%
Hist. Signals25
Avg Return1.22%
Score6.94/10
Win Rate60.00%
Hist. Signals25
Avg Return1.22%
Marubozu White
Score5.59/10
Win Rate58.33%
Hist. Signals12
Avg Return-0.12%
Score5.59/10
Win Rate58.33%
Hist. Signals12
Avg Return-0.12%
WR Oversold
Score6.39/10
Win Rate52.94%
Hist. Signals51
Avg Return1.90%
Score6.39/10
Win Rate52.94%
Hist. Signals51
Avg Return1.90%
Long Upper Shadow
Score6.94/10
Win Rate60.00%
Hist. Signals25
Avg Return1.22%
Score6.94/10
Win Rate60.00%
Hist. Signals25
Avg Return1.22%
WR Oversold
Score6.39/10
Win Rate52.94%
Hist. Signals51
Avg Return1.90%
Score6.39/10
Win Rate52.94%
Hist. Signals51
Avg Return1.90%
Marubozu White
Score5.59/10
Win Rate58.33%
Hist. Signals12
Avg Return-0.12%
Score5.59/10
Win Rate58.33%
Hist. Signals12
Avg Return-0.12%
Technical Analysis of KURA?
- KURA presents a Outperform setup with a Technical Score of 6.31/10. Key technical indicators highlight an RSI of 36.49 and a MACD of -0.06, with the trend anchored by the 50-Day SMA at 9.87. Traders should monitor key support at 7.12 and resistance at 7.93.
